We are happy to announce that BlueClinical is a proud gold sponsor of the 2nd Bioequivalence Workshop by Medicines for Europe, which is scheduled to take place on 26 April 2023 in Brussels, Belgium.
The workshop will provide a platform for an exchange of views between industry, regulators and academia.
You may find out more on the event at: 2nd Bioequivalence Workshop
Contact us for more details or for discussing your clinical development projects at: firstname.lastname@example.org
BlueClinical recognized by Agência Nacional de Inovação (ANI) as an idoneous entity for conducting R&D activities in the field of translational research
BlueClinical is a founding member of the new pan-European CRO Astrum. For more information about the new range of available services, visit the new Company's website at www.astrumcro.com.